Your browser doesn't support javascript.
loading
Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model.
Williamson, Tara; Bai, Ren-Yuan; Staedtke, Verena; Huso, David; Riggins, Gregory J.
  • Williamson T; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Bai RY; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Staedtke V; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Huso D; Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Riggins GJ; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Oncotarget ; 7(42): 68571-68584, 2016 Oct 18.
Article en En | MEDLINE | ID: mdl-27612418

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Transformación Celular Neoplásica / Colon / Neoplasias del Colon / Ensayos Antitumor por Modelo de Xenoinjerto Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Transformación Celular Neoplásica / Colon / Neoplasias del Colon / Ensayos Antitumor por Modelo de Xenoinjerto Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article